S&P 500   3,662.72 (+0.01%)
DOW   29,797.09 (-0.09%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   214.43 (-0.82%)
FB   289.47 (+1.02%)
GOOGL   1,830.55 (+1.96%)
AMZN   3,219.53 (-0.02%)
TSLA   563.25 (-3.68%)
NVDA   544.40 (+1.64%)
BABA   262.27 (-0.66%)
CGC   28.27 (+6.08%)
GE   10.37 (+2.17%)
MU   68.59 (+2.25%)
AMD   94.44 (+1.95%)
T   28.93 (+0.21%)
NIO   46.83 (+3.24%)
F   9.18 (-0.65%)
ACB   10.99 (+12.72%)
NFLX   505.30 (+0.14%)
BA   218.80 (+2.72%)
GILD   61.31 (+0.31%)
DIS   152.60 (+2.11%)
S&P 500   3,662.72 (+0.01%)
DOW   29,797.09 (-0.09%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   214.43 (-0.82%)
FB   289.47 (+1.02%)
GOOGL   1,830.55 (+1.96%)
AMZN   3,219.53 (-0.02%)
TSLA   563.25 (-3.68%)
NVDA   544.40 (+1.64%)
BABA   262.27 (-0.66%)
CGC   28.27 (+6.08%)
GE   10.37 (+2.17%)
MU   68.59 (+2.25%)
AMD   94.44 (+1.95%)
T   28.93 (+0.21%)
NIO   46.83 (+3.24%)
F   9.18 (-0.65%)
ACB   10.99 (+12.72%)
NFLX   505.30 (+0.14%)
BA   218.80 (+2.72%)
GILD   61.31 (+0.31%)
DIS   152.60 (+2.11%)
S&P 500   3,662.72 (+0.01%)
DOW   29,797.09 (-0.09%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   214.43 (-0.82%)
FB   289.47 (+1.02%)
GOOGL   1,830.55 (+1.96%)
AMZN   3,219.53 (-0.02%)
TSLA   563.25 (-3.68%)
NVDA   544.40 (+1.64%)
BABA   262.27 (-0.66%)
CGC   28.27 (+6.08%)
GE   10.37 (+2.17%)
MU   68.59 (+2.25%)
AMD   94.44 (+1.95%)
T   28.93 (+0.21%)
NIO   46.83 (+3.24%)
F   9.18 (-0.65%)
ACB   10.99 (+12.72%)
NFLX   505.30 (+0.14%)
BA   218.80 (+2.72%)
GILD   61.31 (+0.31%)
DIS   152.60 (+2.11%)
S&P 500   3,662.72 (+0.01%)
DOW   29,797.09 (-0.09%)
QQQ   303.85 (+0.13%)
AAPL   123.08 (+0.29%)
MSFT   214.43 (-0.82%)
FB   289.47 (+1.02%)
GOOGL   1,830.55 (+1.96%)
AMZN   3,219.53 (-0.02%)
TSLA   563.25 (-3.68%)
NVDA   544.40 (+1.64%)
BABA   262.27 (-0.66%)
CGC   28.27 (+6.08%)
GE   10.37 (+2.17%)
MU   68.59 (+2.25%)
AMD   94.44 (+1.95%)
T   28.93 (+0.21%)
NIO   46.83 (+3.24%)
F   9.18 (-0.65%)
ACB   10.99 (+12.72%)
NFLX   505.30 (+0.14%)
BA   218.80 (+2.72%)
GILD   61.31 (+0.31%)
DIS   152.60 (+2.11%)
Log in
NYSEARCA:XBI

SPDR S&P Biotech ETF Stock Forecast, Price & News

$132.65
-0.29 (-0.22 %)
(As of 12/2/2020 01:15 PM ET)
Add
Today's Range
$130.88
Now: $132.65
$133.04
50-Day Range
$112.76
MA: $121.55
$133.20
52-Week Range
$62.94
Now: $132.65
$136.04
Volume205,020 shs
Average Volume6.11 million shs
Market Capitalization$6.73 billion
P/E RatioN/A
Dividend Yield0.08%
BetaN/A
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Geographic Exposure of XBI

Currency Exposure of XBI

Sector Exposure of XBI

Industry Exposure of XBI


Basic Details

Issuer SSgA
Fund NameSPDR S&P Biotech ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:XBI
Inception Date1/31/2006
Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio
Phone+1-866-7872257

Fund Focus

Asset ClassEquity
BenchmarkS&P Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$5.93 billion
Average Daily Volume$4.83 million
Discount/Premium0.14%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial
$132.65
-0.29 (-0.22 %)
(As of 12/2/2020 01:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XBI News and Ratings via Email

Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions

How has SPDR S&P Biotech ETF's stock price been impacted by COVID-19 (Coronavirus)?

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, XBI stock has increased by 67.6% and is now trading at $132.40.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than SPDR S&P Biotech ETF?

Wall Street analysts have given SPDR S&P Biotech ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SPDR S&P Biotech ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How often does SPDR S&P Biotech ETF pay dividends? What is the dividend yield for SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF announced a quarterly dividend on Friday, December 20th. Shareholders of record on Monday, December 23rd will be paid a dividend of $0.0009 per share on Thursday, December 26th. This represents a $0.00 dividend on an annualized basis and a yield of 0.00%. The ex-dividend date is Friday, December 20th.
View SPDR S&P Biotech ETF's dividend history
.

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Nasdaq Biotechnology ETF (IBB), The Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

Who are SPDR S&P Biotech ETF's key executives?

SPDR S&P Biotech ETF's management team includes the following people:
  • James E. Ross, President, Trustee (Age 52)
  • Peter A. Ambrosini, Chief Compliance Officer (Age 69)
  • Michael P. Riley, Vice President (Age 44)
  • Gary L. French, Treasurer (Age 64)
  • John W. Clark, Assistant Treasurer (Age 46)
  • Matthew W. Flaherty, Assistant Treasurer (Age 42)
  • Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
  • Mary Moran Zeven, Secretary (Age 52)
  • Scott M. Zoltowski, Assistant Secretary (Age 44)
  • Dave Kelly, Independent Trustee

What is SPDR S&P Biotech ETF's stock symbol?

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Morgan Stanley (21.83%), JPMorgan Chase & Co. (20.11%), Wells Fargo & Company MN (2.45%), Natixis (1.91%), SG Americas Securities LLC (1.67%) and LPL Financial LLC (0.87%).

Which institutional investors are selling SPDR S&P Biotech ETF stock?

XBI stock was sold by a variety of institutional investors in the last quarter, including Raymond James Financial Services Advisors Inc., Wells Fargo & Company MN, IMC Chicago LLC, Private Advisor Group LLC, Commonwealth Equity Services LLC, Bank Julius Baer & Co. Ltd Zurich, JPMorgan Chase & Co., and CWM LLC.

Which institutional investors are buying SPDR S&P Biotech ETF stock?

XBI stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, Natixis, SG Americas Securities LLC, Squarepoint Ops LLC, LPL Financial LLC, Davis R M Inc., OLD Mission Capital LLC, and Blair William & Co. IL.

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SPDR S&P Biotech ETF's stock price today?

One share of XBI stock can currently be purchased for approximately $132.40.

How big of a company is SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF has a market capitalization of $6.72 billion.

What is SPDR S&P Biotech ETF's official website?

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

How can I contact SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.